Table 1.
Immunomodulatory biomaterial | Cargo | Outcome | Reference |
---|---|---|---|
Collagen type I and sulfated chitosan hydrogel | – |
|
[57] |
High-sulfated hyaluronan and collagen hydrogel | – | Increased pro-regenerative macrophage activation | [58] |
Sponge of low-degree-sulfated κ/β-carrageenan | – |
|
[59] |
Silk fibroin hydrogel | – |
|
[60] |
Silk fibroin hydrogel + silica microspheres + silver nanoparticles | – |
|
[61] |
Dextran-based hydrogel + black phosphorus nanosheets + zinc oxide nanoparticles. | – |
|
[62] |
Elastin/Gelatin hydrogel | – |
|
[63] |
Hybrid hydrogel of glycyrrhizic acid and silk fibroin + Zn2+ | – |
|
[64] |
Placenta-derived decellularized ECM hydrogel | – |
|
[65] |
Gelatin methacryloyl hydrogel | IL-6 | Increased survival of skin allografts | [66] |
Po(lylactic acid) electrospun fibers | IL-10 | Macrophage polarization toward a M2 phenotype | [67] |
Hyaluronic acid | anti-TNF-α | Decreased macrophage infiltration Decreased IL-1β levels on Day 1 | [68] |
Alginate hydrogel | FGF-2 | Shift toward M2 phenotype Changes in the cytokine profile |
[69] |
Chitosan–silver hydrogel | bFGF | Stimulated collagen deposition Promoted M2 macrophage polarization | [70] |
Hyaluronic acid, dextran and β-cyclodextrin hydrogel | Resveratrol VEGF plasmid | Decreased levels of IL-1β and TNF-α gene expression. | [71] |
Gelatin-oxidized starch nanofibers | Lawsonia Inermis L. extracts | Reduced inflammatory response. Decreased levels of pro-inflammatory macrophages | [72] |
Hyaluronic acid hydrogel | Extracellular vesicles from mesenchymal stem cells | Promoted M2 macrophage polarization | [73] |
Poly(urethane acrylate) patch | Human dermal fibroblast |
|
[74] |
Chitosan–polyurethane hydrogel | Adipose-derived adult stem cells |
|
[55] |
Fibrin hydrogel | Silver sulfadiazine Adipose-derived stem cells | Reduced expression of TNF-α. Increased neovascularization Increased collagen deposition | [75] |
Aloe Vera hydrogel | Adipose-derived stem cells |
|
[76] |
Collagen scaffold | (miR)-29B | Improved collagen type III/I ratio Higher matrix metalloproteinase (MMP)-8/tissue inhibitor of metalloproteinase (TIMP)-1 | [78] |
β-cyclodextrin and poly(amidoamine) polymer | MMP-9siRNA | Increased content of collagen around the wounded tissues. Decreased infiltration of PMNs leukocytes | [79] |